Background: Even though MRI is an expensive technique, not every lesion or mass of the uterus can be visualized on ultrasound due to obscuration of the pelvis by bowel gas; hence, both studies are mandatory to conclude the uterine mass in addition to the histopathology of the uterine mass. Method: In 90 adult women with uterine masses, transabdominal ultrasound, transvaginal ultrasound, and MRI were performed in all patients. The observations were compared. Results: The clinical manifestations were 63 (70%) had pain, 33 (36.6%) had bleeding PV, 27 (30%) had discharged PV, 6 (6.6%) had a mass abdomen, 6 (6.6%) had loss of weight and appetite pre-menopausal, and 30 (33.3%) were post-menopausal. According to their histopathological report, they were classified into five groups: adenomyosis was affected in 21 patients, fibroids were observed in 42 individuals, endometrial cancer was in 6 patients, and cervical cancer was polyp. Out of ten women, two had adnexal pathology. Conclusion: To localize, characterize, and evaluate the number of uterine lesions, both benign and malignant, along with their staging in pelvic pathologies, MRI was found to be more precise and the gold standard in comparison to USG. Most times, MRI had an edge over USG in detecting endometrial invasion in the case of endometrial carcinoma and staging in the case of cervical carcinoma.
Sule et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: